Kutse

Saatja: EURO Governance <[email protected]> Saadetud: 15.08.2022 18:13 Adressaat: <[email protected]> Koopia: ZAPATA, Tomas <[email protected]>; EURO Governance <[email protected]>; Peep Peterson <[email protected]>; Triin Uusberg <[email protected]>; Elen Ohov <[email protected]>; SM Info <[email protected]>; <[email protected]>; <[email protected]>; Kaisa.Mitt- Alvarez <[email protected]>; <[email protected]>; <[email protected]>; KÖHLER, Kristina <[email protected]> Teema: WHO/Europe A letter from the Regional Director (RC72 the parallel session on Personalized Medicine) Dear Dr Pajusalu, Please find enclosed a letter from Dr Hans Henri P. Kluge, WHO Regional Director for Europe. Sincerely yours, Regional Governance and Languages Unit Regional Directors DivisionWHO Regional Office for EuropeMarmorvej 51, DK-2100 Copenhagen Ø, DenmarkT: &#43;45 45 33 68 51 | WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTÉ WELTGESUNDHEITSORGANISATION Date: 05 August 2022 ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ REGIONAL OFFICE FOR EUROPE BUREAU RÉGIONAL DE L’EUROPE Dr Sander Pajusalu REGIONALBÜRO FÜR EUROPA ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО Head of the Genetics and Personalized Medicine Department Head office: Tartu University Hospital UN City, Marmorvej 51, DK-2100 Copenhagen Ø, Denmark Associate Professor, University of Tartu Tel.: +45 45 33 70 00; Fax: +45 45 33 70 01 Estonia Email: [email protected] Website: http://www.euro.who.int Our reference: RC72 Your reference: Notre référence: invitation Votre référence: Unser Zeichen: Ihr Zeichen: См. наш номер: На Ваш номер: Dear Dr Pajusalu, Invitation to the parallel session on Personalized and Precision Medicine in Europe at the 72nd session of the WHO Regional Committee for Europe, 12–14 September 2022, Tel Aviv, Israel I have the pleasure of inviting you to the parallel session on ‘Personalized and Precision Medicine in Europe’, which will take place on Wednesday, 14 September at 12.30 pm in Tel Aviv, Israel in the framework of the 72nd session of the WHO Regional Committee for Europe (RC72). As you know, the Regional Committee is the highest decision-making body of the 53 Member States of the WHO European Region. Ministers of health and high-level dignitaries meet once a year for a three-day session to shape political commitment and action to improve the health and health conditions of the people living in the Region. This session of the Regional Committee, the first to be held in person since the start of the COVID-19 pandemic, aims to support the further implementation of the European Programme of Work, 2020–2025 – “United Action for Better Health in Europe” and to strengthen its impact at country level. I would be extremely grateful if you would be willing to share the experience from your country and participate in the panel discussion on the role of personalized and precision Medicine in prevention, diagnosis and treatment of diseases. Your insight on the factors which enable implementation of personalized approaches in healthcare will be very much appreciated. Further details could be discussed with Dr Sarah Garner ([email protected]), our Senior Policy Advisor, who will act as your key focal point for this parallel session and will work to enable your participation. I look forward to your participation online in the parallel session and thank you wholeheartedly for your strong support. If your situation changes to allow for your participation in person, please let us know at your earliest convenience, so that we could arrange for your travel and accommodation in Tel Aviv. Yours very truly, Dr Hans Henri P. Kluge Regional Director UN City, Marmorvej 51 Tel.: +45 45 33 70 00 Email: [email protected] DK-2100 Copenhagen Ø Fax: +45 45 33 70 01 Website: http://www.euro.who.int Denmark Encl.: Provisional programme of the Precision Medicine parallel session at the 72nd session of the WHO Regional Committee for Europe Copy for information to: Mr Peep Peterson, Minister of Health and Labour, Ministry of Social Affairs, Suur-Ameerika 1, Tallinn 10129, Estonia, Email: [email protected] , [email protected] , [email protected] Ms Elen Ohov, Adviser European Union Affairs and International Co-operation Department, Ministry of Social Affairs, Suur- Ameerika 1, Tallinn 10122, Estonia, Email: [email protected] Ms Triin Uusberg, Head, European Union Affairs and International Co-operation Department, Ministry of Social Affairs, Suur- Ameerika 1, Tallinn 10129, EstoniaEmail: [email protected] , [email protected] H.E. Ms Katrin Saarsalu-Layachi, Ambassador Extraordinary and Plenipotentiary, Permanent Representative, Permanent Mission of the Republic of Estonia to the United Nations Office and other international organizations in Geneva, Chemin du Petit-Saconnex 28A, Genève CH-1209, Switzerland, Email: [email protected] , [email protected] , Kaisa.Mitt- [email protected] H.E. Mr William Mart Laanemäe, Ambassador Extraordinary and Plenipotentiary, Embassy of the Republic of Estonia, Frederiksgade 19, 4th floor, Copenhagen K 1265, Denmark, Email: [email protected] , [email protected] Ms Kristina Köhler, Liaison Officer, WHO Country Office, Estonia, Paldiski Road 81, Tallinn 10617, Estonia, Email: [email protected] –2– RC 72 Side-Event: Personalized and Precision Medicine in Europe: Leave No One behind Introduction Wednesday 14 September 2022, 12:30-14:00 12:30-12:45 Connection, sound check and interpretation set-up 12:45–12:55 RD WHO Regional Office for Europe, MoH Israel (in-person) Organized by WHO/Europe, Ministry of Health of Israel, - Opening remarks and European Association for Personalized Medicine - Interactive audience quiz Invitees: All 53 Member States, NSAs Spotlight Presentations Scope: 12:55–13:00 The personalized medicine approach for prevention and treatment of cancer Prof. Stefania Boccia ▪ A side event to discuss how the Regional Office can support MS to improve outcomes of a wide range of medical Università Cattolica del Sacro Cuore, Rome (online) conditions by implementing a personalized medicine 13:00–13:05 The personalized medicine approach in public health practice (in-person) approach. Dr Elisabete Weiderpass, Director, International Agency for Research on Cancer (IARC) Objectives: Country Experiences ▪ To outline the personalized medicine approach for prevention and treatment of cancer and public health practice 13:05–13:10 Israel ▪ To hear experiences from MS about their journey to a more Prof. Lina Basel personalized medicine approach, including benefits and Director, The Raphael Recanati Genetics Institute Rabin Medical Center and Schneider challenges Children's Medical Center of Israel (in-person) Estonia ▪ To review the potential for personalized medicine to improve 13:10–13:15 efficiency and outcomes to meet UHC and SDG targets Dr Sander Pajusalu ▪ To discuss how MS would like WHO EURO to support MS to Head of the Genetics and Personalized Medicine Department, Tartu University implement a more personalized medicine approach Hospital; Associate Professor, University of Tartu (online) 13:15–13:25 Moderated discussion Dr Denis Horgan Executive Director, European Alliance for Personalized Medicine (in-person) 13:25-13:35 Member State Interventions / Questions and answers Closing of Event – Key Take Aways 1